[1] 尹伟, 李成忠, 邹多武. 肝硬化急性肾损伤新标准(ICA2015)下治疗应答和预后的回顾性分析及影响因素研究. 肝脏, 2018, 23:201-205.
[2] 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2010年版). 肝脏, 2011, 3:66-82.
[3] 王帅, 胡大荣. 2015年国际腹水俱乐部共识建议:肝硬化患者急性肾损伤的诊断与管理. 临床肝胆病杂志, 2015, 31:1018-1022.
[4] Wang WN, Wu MY, Ma FZ, et al. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.. Clin Nephrol, 2016, 85:21-29.
[5] Piano S, Tonon M, Vettore E, et al. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis. J Hepatol, 2017, 67:1177-1184.
[6] 王晓春, 冯明丽, 杨长青. 肝硬化腹水患者的临床危险因素分析. 肝脏, 2017, 22:224-226.
[7] Yuan W, Zhang YY, Zhang ZG, et al. Risk factors and outcomes of acute kidney injury in patients with hepatitis B virus related acute on chronic liver failure.. Am J Med Sci, 2017, 353:452-458.
[8] 孙雅凤, 李家斌. 289例乙型肝炎肝硬化患者肾功能评估. 实用肝脏病杂志, 2017, 20:427-430. |
